Galecto Biotech

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis and cancer. The company builds on more than 10 years of research into galectins and galectin modulators, which combined with a strong patent estate gives Galecto Biotech a unique platform.

Contact name:

Hans Schambye

Address:

Ole Maaløes Vej 3, 2200 Copenhagen, Denmark

If you can't find it here or have feedback to our website, please do not hesitate to contact me on kp@danskbiotek.dk or 28895854

Copyright 2012 Danskbiotek. All rights reserved.